REFERENCE
Taylor M, Scuffham PA, Chaplin S, Papo NL.An economic evaluation of valsartan for post-MI patients in the UK who are not suitable for treatment with ACE inhibitors. Value in Health 12: 459-465, No. 4, Jun 2009
Rights and permissions
About this article
Cite this article
Valsartan valuable in MI. Pharmacoecon. Outcomes News 584, 4 (2009). https://doi.org/10.2165/00151234-200905840-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905840-00010